Medifast, Inc. Q4 2025 Earnings Call Summary

The company is repositioning itself from a traditional weight loss focus to a broader metabolic health framework to address fundamental metabolic dysfunction rather than just symptoms. Management introduced 'metabolic synchronization,' a science-driven approach designed to reverse metabolic dysfunction by reducing visceral fat while preserving 98% of lean mass. Performance in Q4 2025 showed the first year-over-year increase in coach productivity since mid-2022, rising 6% as coaches adopt the new metab ...